{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:30:10Z","timestamp":1792467010236,"version":"4.5.0"},"reference-count":41,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,22]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Mathematical models are increasingly important in planning for the upcoming chronic hepatitis C (CHC) elimination efforts. Such models require reliable natural history inputs to make accurate predictions on health and economic outcomes. Yet, hepatitis C virus disease progression is known to vary widely in the literature and published inputs are currently outdated. The objectives of this study were to obtain updated estimates of fibrosis progression rates (FPR) in treatment-na\u00efve patients with CHC and to explore sources of heterogeneity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A systematic review was conducted using Ovid-MEDLINE, Ovid-EMBASE and PubMed databases (January 1990 to January 2018) to identify observational studies of hepatic fibrosis in treatment-na\u00efve patients with CHC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes<\/jats:title><jats:p>Stage-constant FPRs were estimated for each study given the reported fibrosis scores and duration of infection. Stage-specific FPRs (ie, F0\u2192F1; F1\u2192F2; F2\u2192F3; F3\u2192F4) were estimated using Markov maximum likelihood estimation. Estimates were pooled using random-effects meta-analysis and heterogeneity was evaluated by stratification and random-effects meta-regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The review identified 111 studies involving 131 groups of patients (n=42 693). The pooled stage-constant FPR was 0.094 (95% CI 0.088 to 0.100); stage-specific FPRs were F0\u2192F1: 0.107 (95% CI 0.097 to 0.118); F1\u2192F2: 0.082 (95% CI 0.074 to 0.091); F2\u2192F3: 0.117 (95% CI 0.107 to 0.129); F3\u2192F4: 0.116 (95% CI 0.104 to 0.131). Stratified analysis revealed substantial variation in progression by study population. Meta-regression indicated associations between progression and infection age, duration, source, viral genotype and study population. Findings indicate that FPRs display substantial heterogeneity across study populations and pooled values from more homogenous subpopulations should be considered when estimating prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This large meta-analysis presents updated prognostic estimates for CHC derived from newer studies using better diagnostic methods and improves estimates for important patient populations in terms of clinical policy (eg, injection drug users, non-clinical populations, liver clinic patients) and should be a valuable resource for patients, clinicians and clinical policymakers.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-027491","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T09:55:25Z","timestamp":1573552525000},"page":"e027491","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-3497","authenticated-orcid":false,"given":"Aysegul","family":"Erman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawnya","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Bielecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grootendorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hla-Hla","family":"Thein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"2024052012050549000_9.11.e027491.1","doi-asserted-by":"crossref","first-page":"0001","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"2024052012050549000_9.11.e027491.2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2024052012050549000_9.11.e027491.3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260711"},{"key":"2024052012050549000_9.11.e027491.4","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2001.001003197.x"},{"key":"2024052012050549000_9.11.e027491.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22375"},{"key":"2024052012050549000_9.11.e027491.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00097-0"},{"key":"2024052012050549000_9.11.e027491.7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.026393"},{"key":"2024052012050549000_9.11.e027491.8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26644"},{"key":"2024052012050549000_9.11.e027491.9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jvh.12875","article-title":"Hepatitis C: the beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe","volume":"25","author":"Papatheodoridis","year":"2018","journal-title":"J Viral Hepat"},{"key":"2024052012050549000_9.11.e027491.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00851.x"},{"key":"2024052012050549000_9.11.e027491.11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.14745\/ccdr.v40i19a02","article-title":"Estimated prevalence of hepatitis C virus infection in Canada, 2011","volume":"40","author":"Trubnikov","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"2024052012050549000_9.11.e027491.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07642-8"},{"key":"2024052012050549000_9.11.e027491.13","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36993"},{"key":"2024052012050549000_9.11.e027491.14","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27831"},{"key":"2024052012050549000_9.11.e027491.15","doi-asserted-by":"crossref","first-page":"0047","DOI":"10.1055\/s-2000-9258","article-title":"Fibrosis in patients with chronic hepatitis C: detection and significance","volume":"20","author":"Poynard","year":"2000","journal-title":"Semin Liver Dis"},{"key":"2024052012050549000_9.11.e027491.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26905"},{"key":"2024052012050549000_9.11.e027491.17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306997"},{"key":"2024052012050549000_9.11.e027491.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2011.01481.x"},{"key":"2024052012050549000_9.11.e027491.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.016"},{"key":"2024052012050549000_9.11.e027491.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00162-4"},{"key":"2024052012050549000_9.11.e027491.21","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.4.563"},{"key":"2024052012050549000_9.11.e027491.22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2893.2003.00484.x","article-title":"Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection","volume":"11","author":"Yi","year":"2004","journal-title":"J Viral Hepat"},{"key":"2024052012050549000_9.11.e027491.23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2008.08.006","article-title":"Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C","volume":"6","author":"Terrault","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024052012050549000_9.11.e027491.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05555.x"},{"key":"2024052012050549000_9.11.e027491.25","doi-asserted-by":"crossref","unstructured":"Higgins JP , Green S . Cochrane Handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons, Ltd, 2008.","DOI":"10.1002\/9780470712184"},{"key":"2024052012050549000_9.11.e027491.26","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060410"},{"key":"2024052012050549000_9.11.e027491.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2024052012050549000_9.11.e027491.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.06.008"},{"key":"2024052012050549000_9.11.e027491.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.07.004"},{"key":"2024052012050549000_9.11.e027491.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000135170.54913.9d"},{"key":"2024052012050549000_9.11.e027491.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30826.x"},{"key":"2024052012050549000_9.11.e027491.32","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1187"},{"key":"2024052012050549000_9.11.e027491.33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jvh.12846","article-title":"Estimating chronic hepatitis C prognosis using transient elastography\u2010based liver stiffness: a systematic review and meta\u2010analysis","volume":"25","author":"Erman","year":"2018","journal-title":"J Viral Hepat"},{"key":"2024052012050549000_9.11.e027491.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.097"},{"key":"2024052012050549000_9.11.e027491.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24608"},{"key":"2024052012050549000_9.11.e027491.36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2036.2007.03309.x","article-title":"The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C","volume":"25","author":"Lo Iacono","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2024052012050549000_9.11.e027491.37","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.050302"},{"key":"2024052012050549000_9.11.e027491.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.08.032"},{"key":"2024052012050549000_9.11.e027491.39","doi-asserted-by":"crossref","unstructured":"R\u00fccker G , Schwarzer G , Carpenter JR , et al . Undue reliance on I 2 in assessing heterogeneity may mislead. BMC Med Res Methodol 2008;8.doi:10.1186\/1471-2288-8-79","DOI":"10.1186\/1471-2288-8-79"},{"key":"2024052012050549000_9.11.e027491.40","doi-asserted-by":"crossref","first-page":"E662","DOI":"10.9778\/cmajo.20170048","article-title":"Model-Based projection of health and economic effects of screening for hepatitis C in Canada","volume":"5","author":"Wong","year":"2017","journal-title":"CMAJ Open"},{"key":"2024052012050549000_9.11.e027491.41","doi-asserted-by":"crossref","unstructured":"Erman A , Wong WWL , Feld JJ , et al . The health impact of delaying direct-acting antiviral treatment for chronic hepatitis C: a decision-analytic approach. Liver Int 2019. doi:doi:10.1111\/liv.14247. [Epub ahead of print: 11 Sep 2019].","DOI":"10.1111\/liv.14247"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-027491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T19:21:10Z","timestamp":1716232870000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-027491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,11]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bmjopen-2018-027491"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-027491","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}